ARVEE LABORATORIES (INDIA)
|
ARVEE LABORATORIES (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 3.74 | 2.34 | 2.43 | 4.17 | 4.11 |
| CEPS(Rs) | 5.63 | 4.44 | 4.61 | 4.16 | 4.19 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 25.46 | 21.72 | 19.39 | 33.82 | 29.53 |
| Tax Rate(%) | 33.19 | 25.38 | 26.48 | 25.61 | 11.05 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.87 | 13.95 | 12.75 | 13.26 | 11.25 |
| EBIT Margin(%) | 10.68 | 9.47 | 8.90 | 8.98 | 7.61 |
| Pre Tax Margin(%) | 10.05 | 8.55 | 7.69 | 6.80 | 4.63 |
| PAT Margin (%) | 6.71 | 6.38 | 5.65 | 5.06 | 4.12 |
| Cash Profit Margin (%) | 10.10 | 12.14 | 10.73 | 10.10 | 8.40 |
| Performance Ratios | |||||
| ROA(%) | 10.65 | 6.46 | 7.17 | 6.50 | 5.57 |
| ROE(%) | 15.84 | 11.36 | 13.38 | 13.17 | 14.97 |
| ROCE(%) | 23.35 | 13.33 | 15.99 | 15.79 | 14.10 |
| Asset Turnover(x) | 1.59 | 1.01 | 1.27 | 1.28 | 1.35 |
| Sales/Fixed Asset(x) | 2.03 | 1.41 | 1.83 | 1.97 | 2.54 |
| Working Capital/Sales(x) | 4.82 | 3.97 | 6.53 | 8.48 | 11.52 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.49 | 0.71 | 0.55 | 0.51 | 0.39 |
| Receivable days | 72.55 | 90.55 | 55.46 | 57.98 | 77.78 |
| Inventory Days | 30.63 | 59.55 | 53.54 | 44.51 | 42.44 |
| Payable days | 82.15 | 157.69 | 121.18 | 100.36 | 85.09 |
| Valuation Parameters | |||||
| PER(x) | 23.54 | 48.68 | 22.80 | 5.63 | 7.67 |
| PCE(x) | 15.64 | 25.60 | 12.01 | 5.64 | 7.52 |
| Price/Book(x) | 3.46 | 5.23 | 2.86 | 1.39 | 2.13 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.58 | 3.07 | 1.34 | 0.63 | 0.80 |
| EV/Core EBITDA(x) | 11.25 | 20.16 | 9.56 | 4.52 | 6.73 |
| EV/EBIT(x) | 14.81 | 32.41 | 15.01 | 7.06 | 10.52 |
| EV/CE(x) | 2.51 | 3.20 | 1.54 | 0.86 | 1.18 |
| M Cap / Sales | 1.58 | 3.11 | 1.29 | 0.57 | 0.63 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 52.12 | -14.88 | 4.31 | -17.27 | 14.91 |
| Core EBITDA Growth(%) | 40.61 | -7.32 | 4.04 | -2.47 | -11.77 |
| EBIT Growth(%) | 71.58 | -9.45 | 3.42 | -2.38 | -20.34 |
| PAT Growth(%) | 60.04 | -3.87 | 16.46 | 1.60 | 107.77 |
| EPS Growth(%) | 60.03 | -3.86 | -41.77 | 1.60 | 107.77 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.04 | 0.13 | 0.42 | 0.21 | 0.79 |
| Current Ratio(x) | 2.44 | 1.75 | 1.40 | 1.43 | 1.29 |
| Quick Ratio(x) | 1.92 | 1.33 | 0.99 | 0.91 | 1.01 |
| Interest Cover(x) | 16.89 | 10.31 | 7.32 | 4.13 | 2.56 |
| Total Debt/Mcap(x) | 0.01 | 0.02 | 0.15 | 0.15 | 0.37 |
Compare Financial Ratios of peers of ARVEE LABORATORIES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ARVEE LABORATORIES (INDIA) | ₹223.9 Cr | 8.3% | -0% | 38.8% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹150,106.0 Cr | 4% | 9.7% | 25.7% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹79,629.4 Cr | 7.9% | 35.1% | 139.9% | Stock Analytics | |
| SRF | ₹77,525.5 Cr | 6.1% | 8.2% | 8.6% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹40,277.6 Cr | -0.8% | -13% | 0.9% | Stock Analytics | |
| DEEPAK NITRITE | ₹32,593.8 Cr | 1.2% | -7.2% | 20.3% | Stock Analytics | |
ARVEE LABORATORIES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ARVEE LABORATORIES (INDIA) | 8.3% |
-0% |
38.8% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
